SEXUALITY AFTER MENOPAUSE

SEXUAL DYSFUNCTION, RELATED FACTORS, AND THE ASSOCIATION OF VAGINAL HORMONE THERAPY

Authors

DOI:

https://doi.org/10.35919/rbsh.v37.1390

Keywords:

Female sexuality, Postmenopause, Sexual dysfunction, Vaginal hormone therapy, Aging

Abstract

Introduction: Female sexuality is a central dimension of health and quality of life, but it is often under-recognized in post-menopause, a phase in which biological and sociocultural factors can influence sexual experience. Sexual dysfunction (SD) is frequent during this period and is still under-addressed in clinical practice. Objective: To analyze the prevalence of SD, associated factors, and the role of vaginal hormone therapy in sexual function in postmenopausal women, regardless of sexual partner status. Methodology: Observational cross-sectional study with 108 postmenopausal women attending a gynecology outpatient clinic in Passo Fundo-RS. Sexual function was assessed using the 6-item Female Sexual Function Index (FSFI-6). Results: The prevalence of SD among the 108 patients was 77.8%. Among those with SD, 72.6% had a stable sexual partner (p=0.013), while among patients without SD, 95.8% had a stable sexual partner. SD was more prevalent with increasing age (p=0.041). Women using vaginal HRT experienced less sexual dysfunction compared to those not using HRT (p=0.045). Conclusion: Sexual dysfunction was prevalent among postmenopausal women. Vaginal hormone therapy was associated with improved sexual function, regardless of sexual partner, reinforcing sexuality as an individual dimension of women's health.

Downloads

Download data is not yet available.

Author Biographies

Ana Flavia Azevedo Zarowny, Universidade de Passo Fundo

Acadêmica, Faculdade de Medicina, Universidade de Passo Fundo (UPF). Passo Fundo, RS, Brasil. 

Juliana Bosso Taniguchi, Faculdade de Medicina, Universidade de Passo Fundo

Doutorado, Faculdade de Medicina, Universidade de Passo Fundo (UPF). Passo Fundo, RS, Brasil. 

Isadora Dominiak da Silveira, Universidade de Passo Fundo

 

 

Luíza Ramos Colpo, Universidade de Passo Fundo

Acadêmica, Faculdade de Medicina, Universidade de Passo Fundo (UPF). Passo Fundo, RS, Brasil. 

Dariane Alberti, Hospital São Vicente de Paulo

Residente, Residência de Ginecologia e Obstetrícia, Hospital São Vicente de Paulo (HSVP). Passo Fundo, RS, Brasil. 

Karen, Universidade de Passo Fundo

Profa. Titular da Faculdade de Medicina da Universidade de Passo Fundo, RS, Brasil, Residência de Ginecologia e Obstetrícia, Hospital São Vicente de Paulo (HSVP). Passo Fundo, RS, Brasil.

References

ABDO, C. H. N. et al. Perfil sexual da população brasileira: resultados do Estudo do Comportamento Sexual (ECOS). Revista Brasileira de Medicina, São Paulo, v. 59, n. 4, p. 250–257, 2002. Disponível em: https://arca.fiocruz.br/items/56dc5f5f-6a45-403b-9bb4-2c749b721f75. Acesso em: 18 jan. 2026.

ASSOCIAÇÃO BRASILEIRA DE CLIMATÉRIO (SOBRAC). Consenso Brasileiro de Terapêutica Hormonal do Cli-matério. São Paulo: SOBRAC, 2024. Disponível em: https://sobrac.org.br/acesse-o-consenso-brasileiro-de-th-do-climaterio-2024/. Acesso em: 27 jan. 2026.

BASSON, R. Women’s sexual dysfunction: revised and expanded definitions. Canadian Medical Association Journal, Ottawa, v. 172, n. 10, p. 1327–1333, 2005. DOI: 10.1503/cmaj.1020174.

CABRAL, P. U. L. et al. Influência dos sintomas climatéricos sobre a função sexual de mulheres de meia-idade. Revista Brasileira de Ginecologia e Obstetrícia, Rio de Janeiro, v. 34, n. 7, p. 329–334, 2012. DOI: 10.1590/S0100-72032012000700007.

DALL’AGNO, M. L. et al. Validation of the six-item Female Sexual Function Index in middle-aged Brazilian women. Revista Brasileira de Ginecologia e Obstetrícia, Rio de Janeiro, v. 41, n. 7, p. 432–439, 2019. DOI: 10.1055/s-0039-1692694.

DENNERSTEIN, L. et al. Sexuality, hormones and the menopausal transition. Maturitas, Amsterdam, v. 26, n. 2, p. 83–93, 1997. DOI: 10.1016/s0378-5122(96)01093-6.

GUENDLER, J. A. et al. Analysis of the Measurement Properties of the Female Sexual Function Index 6-item Version (FSFI-6) in a Postpartum Brazilian Population. Revista Brasileira de Ginecologia e Obstetrícia, v. 45, n. 2, p. 89-95, 2023. DOI: 10.1055/s-0043-1764496.

NORTH AMERICAN MENOPAUSE SOCIETY ADVISORY PANEL. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, New York, v. 29, n. 7, p. 767–794, jul. 2022. DOI: 10.1097/GME.0000000000002028.

PARISH, S. J. et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symp-toms of vulvovaginal atrophy. International Journal of Women’s Health, [s. l.], v. 5, p. 437–447, 2013. DOI: 10.2147/IJWH.S44579.

ROSEN, R. et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex & Marital Therapy, Philadelphia, v. 26, n. 2, p. 191–208, 2000. DOI: 10.1080/009262300278597.

THORNTON, K. et al. Menopause and sexuality. Endocrinology and Metabolism Clinics of North America, Phil-adelphia, v. 44, n. 3, p. 649–661, set. 2015. DOI: 10.1016/j.ecl.2015.05.009.

WORLD HEALTH ORGANIZATION. Defining sexual health: report of a technical consultation on sexual health. Geneva: World Health Organization, 2002. Disponível em: https://www.worldsexualhealth.net/_files/ugd/793f03_f90b7e05773541739b7c20cf10b63ed7.pdf?index=true. Acesso em: 17 jan. 2026.

Published

2026-11-20

How to Cite

Zarowny, A. F. A., Taniguchi, J. B., Silveira, I. D. da, Colpo, L. R., Alberti, D., & Karen. (2026). SEXUALITY AFTER MENOPAUSE: SEXUAL DYSFUNCTION, RELATED FACTORS, AND THE ASSOCIATION OF VAGINAL HORMONE THERAPY. Revista Brasileira De Sexualidade Humana, 37, 1390. https://doi.org/10.35919/rbsh.v37.1390

Issue

Section

Trabalhos de Pesquisa